Figure 11.

Ad5-ASFV-vaccinee that survived. (A) Antibody response by the lone survivor that was immunized with the Ad5-ASFV without adjuvant. The half-circle indicates the p62-specific IgG responses by the survivor compared to the mean IgG responses (solid square) by the other four group mates that succumbed after challenge. Post-prime is indicated by PP and post-boost by PB. (B) Temperature, weight change, and viremia in blood and nasal fluid post-challenge. (C) Viremia expressed in Log base 10 of the CN/mL for each respective tissue.